论文信息 - Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial - 字舞流文

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial

H. Morreau | T. van Wezel | H. Gelderblom | T. Links | J. V. D. van der Hoeven | E. Kapiteijn | R. van Eijk | N. V. van Erp | H. Guchelaar | D. de Wit | H. Morreau | T. Wezel | D. Wit | N. P. Erp | T. Schneider | H. Guchelaar | Thera P. Links | J.J.M. van der Hoeven | R. Eijk | Hans Morreau | D. D. Wit